Randall Schatzman
Chief Executive Officer bei BOLT BIOTHERAPEUTICS, INC.
Vermögen: 18 003 $ am 31.03.2024
Profil
Randall C.
Schatzman was the founder of Lundbeck Seattle BioPharmaceuticals, Inc. founded in 2004, where he held the position of President, Chief Executive Officer & Director from 2013 to 2018.
Currently, he is the Chief Executive Officer & Director at Bolt Biotherapeutics, Inc. since 2019 and also holds a managerial position at AlderBio Holdings LLC.
Previously, he worked as Director-Gene Discovery at Mercator Genetics, Inc. from 1995 to 1999, Director at Vitaeris, Inc., Senior Vice President-Discovery Research at Celltech R&D, Inc., and Principal at Syntex, Inc. Dr. Schatzman holds a doctorate degree from Emory University and an undergraduate degree from Purdue University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.03.2024 | 12 859 ( 0,03% ) | 18 003 $ | 31.03.2024 |
Aktive Positionen von Randall Schatzman
| Unternehmen | Position | Beginn |
|---|---|---|
| BOLT BIOTHERAPEUTICS, INC. | Chief Executive Officer | 01.07.2019 |
| AlderBio Holdings LLC | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Randall Schatzman
| Unternehmen | Position | Ende |
|---|---|---|
| ALDER BIOPHARMACEUTICALS, INC. | Founder | 20.03.2018 |
Mercator Genetics, Inc.
 Mercator Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Progenitor, Inc., Mercator Genetics, Inc. develops gene therapy programs for asthma, schizophrenia, and cancer. The private company is based in Menlo Park, CA. Mercator Genetics was acquired by Progenitor, Inc. on February 18, 1997 for $22 million. | Corporate Officer/Principal | 01.01.1999 |
Vitaeris, Inc.
 Vitaeris, Inc. BiotechnologyHealth Technology Vitaeris, Inc. develops new treatment options for chronic inflammatory diseases. The company was founded by Kevin Chow, Patrick A. Robinson and Noel F. Hall in 2016 and is headquartered in Vancouver, Canada. | Director/Board Member | - |
| Syntex, Inc. | Corporate Officer/Principal | - |
Celltech R&D, Inc.
 Celltech R&D, Inc. Drugstore ChainsRetail Trade Celltech R&D, Inc. provides research and development services for pharmaceutical products. The private company is based in Bothell, WA. | Corporate Officer/Principal | - |
Ausbildung von Randall Schatzman
| Emory University | Doctorate Degree |
| Purdue University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BOLT BIOTHERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Mercator Genetics, Inc.
Mercator Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Progenitor, Inc., Mercator Genetics, Inc. develops gene therapy programs for asthma, schizophrenia, and cancer. The private company is based in Menlo Park, CA. Mercator Genetics was acquired by Progenitor, Inc. on February 18, 1997 for $22 million. | Commercial Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
Celltech R&D, Inc.
Celltech R&D, Inc. Drugstore ChainsRetail Trade Celltech R&D, Inc. provides research and development services for pharmaceutical products. The private company is based in Bothell, WA. | Retail Trade |
| Syntex, Inc. | Miscellaneous |
| AlderBio Holdings LLC | |
Vitaeris, Inc.
Vitaeris, Inc. BiotechnologyHealth Technology Vitaeris, Inc. develops new treatment options for chronic inflammatory diseases. The company was founded by Kevin Chow, Patrick A. Robinson and Noel F. Hall in 2016 and is headquartered in Vancouver, Canada. | Health Technology |
